Literature DB >> 6812684

Bone marrow transplantation: 1982.

H E Kay.   

Abstract

Mesh：

Year:  1982        PMID： 6812684     DOI： 10.1136/bmj.285.6351.1296

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  21 in total

1.  Marrow transplantation for thalassaemia.

Authors:  E D Thomas; C D Buckner; J E Sanders; T Papayannopoulou; C Borgna-Pignatti; P De Stefano; K M Sullivan; R A Clift; R Storb
Journal:  Lancet       Date:  1982-07-31       Impact factor: 79.321

2.  Bone marrow transplantation for inborn errors.

Authors:  J R Hobbs
Journal:  Lancet       Date:  1981-10-03       Impact factor: 79.321

3.  Kettering Award Lecture. The role of marrow transplantation in the eradication of malignant disease.

Authors:  E D Thomas
Journal:  Cancer       Date:  1982-05-15       Impact factor: 6.860

4.  The role of bone marrow transplantation in the treatment of acute leukemia in remission.

Authors:  E Beutler; R McMillan; W Spruce
Journal:  Blood       Date:  1982-06       Impact factor: 22.113

5.  A randomized study of the prevention of acute graft-versus-host disease.

Authors:  N K Ramsay; J H Kersey; L L Robison; P B McGlave; W G Woods; W Krivit; T H Kim; A I Goldman; M E Nesbit
Journal:  N Engl J Med       Date:  1982-02-18       Impact factor: 91.245

6.  Results of immunosuppression in 170 cases of severe aplastic anaemia. Report of the European Group of Bone Marrow Transplant (EGBMT).

Authors:  E Gluckman; A Devergie; A Poros; P Degoulet
Journal:  Br J Haematol       Date:  1982-08       Impact factor: 6.998

7.  Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia.

Authors:  H G Prentice; H A Blacklock; G Janossy; K F Bradstock; D Skeggs; G Goldstein; A V Hoffbrand
Journal:  Lancet       Date:  1982-03-27       Impact factor: 79.321

8.  Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow transplantation.

Authors:  A H Filipovich; P B McGlave; N K Ramsay; G Goldstein; P I Warkentin; J H Kesey
Journal:  Lancet       Date:  1982-06-05       Impact factor: 79.321

9.  Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man.

Authors:  A Keating; J W Singer; P D Killen; G E Striker; A C Salo; J Sanders; E D Thomas; D Thorning; P J Fialkow
Journal:  Nature       Date:  1982-07-15       Impact factor: 49.962

10.  Treatment of chronic granulocytic leukemia with chemoradiotherapy and transplantation of marrow from identical twins.

Authors:  A Fefer; M A Cheever; P D Greenberg; F R Appelbaum; C N Boyd; C D Buckner; H G Kaplan; R Ramberg; J E Sanders; R Storb; E D Thomas
Journal:  N Engl J Med       Date:  1982-01-14       Impact factor: 91.245
View more
  1 in total

Review 1.  Clinical pharmacokinetics in infants and children. A reappraisal.

Authors:  G L Kearns; M D Reed
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.